» Articles » PMID: 16505827

Subacute Human Spinal Cord Contusion: Few Lymphocytes and Many Macrophages

Overview
Journal Spinal Cord
Specialty Neurology
Date 2006 Mar 1
PMID 16505827
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Study Design: Clinicopathological correlation of three cases of subacute cervical spinal cord contusions.

Objective: To correlate the pathology of subacute cervical spinal cord injury (SCI) with imaging and clinical-functional studies, and to compare with findings from previous human SCI studies and animal models of SCI.

Setting: Department of Pathology, SUNY-Upstate Medical University, Syracuse, NY, USA.

Method: Post mortem pathology report.

Case Report/results: The clinical, radiological, and pathological findings of three cases of subacute spinal cord contusions are described in detail. The postinjury survival periods were 15, 20, and 60 days, respectively. Extensive microglia/macrophage infiltrations without significant lymphocytes are seen in all cases. Free radical injury as assessed by immunocytochemistry for 4-hydroxynonenal and nitrotyrosine showed a labeling pattern parallel to that of the macrophage distribution at 15 days, but no significant labeling in the injury sites at 20 and 60 days.

Conclusion: The present report, though limited in sample size, shows plenty of activated microglia/macrophages in human SCI up to 60 days postinjury. This observation not only confirms similar findings in previous studies, but also raises an intriguing question of potential interactions between these activated microglia/macrophages and the experimental therapy, proposed by some authors, of injecting exogenously activated macrophages to promote SCI repair. The small number of human SCI cases (in this as well as in most other single medical centers) available for detailed study illustrates the need for the establishment of a consortium of human SCI tissue banks.

Citing Articles

Peripheral immune reactions following human traumatic spinal cord injury: the interplay of immune activation and suppression.

Coenen H, Somers V, Fraussen J Front Immunol. 2024; 15():1495801.

PMID: 39664385 PMC: 11631733. DOI: 10.3389/fimmu.2024.1495801.


Identification of immune-related hub genes in spinal cord injury.

Gao X, Su Y, Shan S, Qian W, Zhang Z Eur J Med Res. 2024; 29(1):483.

PMID: 39367463 PMC: 11451166. DOI: 10.1186/s40001-024-02075-0.


Modulating neuroinflammation through molecular, cellular and biomaterial-based approaches to treat spinal cord injury.

Lee C, Chooi W, Ng S, Chew S Bioeng Transl Med. 2023; 8(2):e10389.

PMID: 36925680 PMC: 10013833. DOI: 10.1002/btm2.10389.


Dynamic Diversity of Glial Response Among Species in Spinal Cord Injury.

Perez J, Gerber Y, Perrin F Front Aging Neurosci. 2021; 13:769548.

PMID: 34899275 PMC: 8662749. DOI: 10.3389/fnagi.2021.769548.


The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice.

Li H, Kong W, Chambers C, Yu D, Ganea D, Tuma R Cell Immunol. 2018; 329:1-9.

PMID: 29784129 PMC: 6447028. DOI: 10.1016/j.cellimm.2018.02.016.